Trevi Therapeutics (TRVI) Share-based Compensation Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 55.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.92% |
| Dec 31, 2025 | 39.15% |
| Sep 30, 2025 | 29.75% |
| Jun 30, 2025 | 38.58% |
| Mar 31, 2025 | 17.91% |
| Dec 31, 2024 | 19.30% |
| Sep 30, 2024 | 15.03% |
| Jun 30, 2024 | 14.79% |
| Mar 31, 2024 | 0.23% |
| Dec 31, 2023 | 1.54% |
| Sep 30, 2023 | -3.40% |
| Jun 30, 2023 | -3.46% |
| Mar 31, 2023 | -7.49% |
| Dec 31, 2022 | 10.33% |
| Sep 30, 2022 | 15.32% |
| Jun 30, 2022 | 29.94% |
| Mar 31, 2022 | 71.54% |
| Dec 31, 2021 | 42.91% |
| Sep 30, 2021 | 64.64% |
| Jun 30, 2021 | 94.02% |
| Mar 31, 2021 | 101.32% |